Nuzenio

Casdatifan

Casdatifan news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Arcus Biosciences (RCUS) Stock Gets Fair Value Bump After Casdatifan Optimism - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 05:10:00 GMTArcus Biosciences (RCUS) Stock Can Casdatifan Carry Mounting Losses - simplywall.stsimplywall.st · Thu, 06 Aug 2026 23:02:37 GMTSalim Syed Initiates Buy on Arcus, Citing Casdatifan’s Foundational RCC Potential and Diversified Late-Stage Pipeline Ahead of 2026 Inflection Data - tipranks.comtipranks.com · Thu, 06 Aug 2026 16:44:58 GMTArcus Biosciences: Broad Casdatifan Strategy in ccRCC Supports Buy Rating with Unchanged $45 Price Target - tipranks.comtipranks.com · Thu, 06 Aug 2026 13:19:28 GMTRCUS: Advanced casdatifan in ccRCC, secured new partnerships, and maintained strong cash runway - TradingViewTradingView · Wed, 05 Aug 2026 20:14:38 GMTArcus Biosciences reports Q2 2026 results: $41M revenue, $775M cash, $91M net loss - TradingViewTradingView · Wed, 05 Aug 2026 20:13:01 GMTHow Investors May Respond To Arcus Biosciences (RCUS) Expanding ARC-20 With New Kidney Cancer Combo - webull.comwebull.com · Mon, 03 Aug 2026 06:49:35 GMTARC-20 Phase I trial: Casdatifan shows durable response in kidney cancer - Oncology CentralOncology Central · Wed, 29 Jul 2026 07:36:18 GMT

Timeline

Sat, 08 Aug 2026 05:10:00 GMTArcus Biosciences (RCUS) Stock Gets Fair Value Bump After Casdatifan Optimism - Yahoo Finance
Thu, 06 Aug 2026 23:02:37 GMTArcus Biosciences (RCUS) Stock Can Casdatifan Carry Mounting Losses - simplywall.st
Thu, 06 Aug 2026 16:44:58 GMTSalim Syed Initiates Buy on Arcus, Citing Casdatifan’s Foundational RCC Potential and Diversified Late-Stage Pipeline Ahead of 2026 Inflection Data - tipranks.com
Thu, 06 Aug 2026 13:19:28 GMTArcus Biosciences: Broad Casdatifan Strategy in ccRCC Supports Buy Rating with Unchanged $45 Price Target - tipranks.com
Wed, 05 Aug 2026 20:14:38 GMTRCUS: Advanced casdatifan in ccRCC, secured new partnerships, and maintained strong cash runway - TradingView
Wed, 05 Aug 2026 20:13:01 GMTArcus Biosciences reports Q2 2026 results: $41M revenue, $775M cash, $91M net loss - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Casdatifan.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.